UPDATE 1-Fresenius nudges up Kabi earnings guidance
July 31, 2018 at 01:52 AM EDT
Fresenius SE nudged up its earnings guidance for its Kabi generic drugs unit on Tuesday after it was boosted by a European ruling not to ban HES medicines.